Related references
Note: Only part of the references are listed.Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Human Macrophage Foam Cell Formation and the Inflammatory Response Induced by Very Low-Density Lipoprotein
Lazar A. Bojic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
FoxOs Integrate Pleiotropic Actions of Insulin in Vascular Endothelium to Protect Mice from Atherosclerosis
Kyoichiro Tsuchiya et al.
CELL METABOLISM (2012)
PPARs at the crossroads of lipid signaling and inflammation
Walter Wahli et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
The Oxysterol 24(S),25-Epoxycholesterol Attenuates Human Smooth Muscle-Derived Foam Cell Formation Via Reduced Low-Density Lipoprotein Uptake and Enhanced Cholesterol Efflux
Michael M. Beyea et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Type I Collagen Cleavage Is Essential for Effective Fibrotic Repair after Myocardial Infarction
Zengxuan Nong et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Karin E. Bornfeldt et al.
CELL METABOLISM (2011)
Reversal of Hyperlipidemia With a Genetic Switch Favorably Affects the Content and Inflammatory State of Macrophages in Atherosclerotic Plaques
Jonathan E. Feig et al.
CIRCULATION (2011)
Phenotypic modulation of macrophages in response to plaque lipids
Samantha Adamson et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
Esther M. M. Ooi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
Harold E. Bays et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
PPARδ inhibits IL-1β-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra
H. J. Kim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
The Impact of Macrophage Insulin Resistance on Advanced Atherosclerotic Plaque Progression
Ira Tabas et al.
CIRCULATION RESEARCH (2010)
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
R. A. DeFronzo
DIABETOLOGIA (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Lipid Incorporation Inhibits Src-Dependent Assembly of Fibronectin and Type I Collagen by Vascular Smooth Muscle Cells
Matthew J. Frontini et al.
CIRCULATION RESEARCH (2009)
FoxO1 Links Insulin Resistance to Proinflammatory Cytokine IL-1β Production in Macrophages
Dongming Su et al.
DIABETES (2009)
Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity
Kihwa Kang et al.
CELL METABOLISM (2008)
Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
Justin I. Odegaard et al.
CELL METABOLISM (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D. Barish et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
Yasunori Takata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease
Carlos Fernández-Hernando et al.
CELL METABOLISM (2007)
Subendothelial lipoprotein retention as the initiating process in atherosclerosis -: Update and therapeutic implications
Ira Tabas et al.
CIRCULATION (2007)
Increasing cardiovascular disease burden due to diabetes mellitus - The Framingham Heart Study
Caroline S. Fox et al.
CIRCULATION (2007)
PPARδ modulates lipopolysaccharide-induced TNFα inflammation signaling in cultured cardiomyocytes
Guoliang Ding et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis
Marie-Julie Dubois et al.
NATURE MEDICINE (2006)
Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis
J Baumgartl et al.
CELL METABOLISM (2006)
Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions
S Han et al.
CELL METABOLISM (2006)
PPARδ:: a dagger in the heart of the metabolic syndrome
GD Barish et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PPARδ regulates glucose metabolism and insulin sensitivity
CH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The PPARδ agonist GW0742X reduces atherosclerosis in LDLR-/- mice
TL Graham et al.
ATHEROSCLEROSIS (2005)
Morphologic findings of coronary atherosclerotic plaques in diabetics - A postmortem study
AP Burke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Transcriptional repression of atherogenic inflammation:: Modulation by PPARδ
CH Lee et al.
SCIENCE (2003)
TRB3:: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver
KY Du et al.
SCIENCE (2003)
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ) -: Synthesis and biological activity
ML Sznaidman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Share Paper
